- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04430114
MuLtibranchEd Graft for OPen RepAir of ThoRacoabdominal Aneurysms
November 10, 2022 updated by: Bertoglio Luca, IRCCS San Raffaele
DediCated MuLtibranchEd DacrOn Graft for OPen RepAir of ThoRacoabdominal Aneurysms - CLEOPATRA Study
The objective of the study is the evaluation of the technical success and clinical outcomes of the surgical treatment of thoraco-abdominal aortic aneurysms treated by Jotec "TAAA spinal loop graft" "custom made "CE equivalent" branched prosthesis, compared with the patient cohort already treated with standard and / or bench-top prostheses Gelweave ™ Coselli Thoracoabdominal Grafts.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milano, Italy, 20132
- San Raffaele Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients aged ≥ 18 years;
- patients candidates for surgical treatment of thoraco-abdominal aorta of the II and III type sec. Crawford using "TAAA spinal loop graft" "custom made CE equivalent" prosthesis
Exclusion Criteria:
• patients aged ≤ 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TAAA spinal loop graft
|
Jotec "TAAA spinal loop graft" "custom made CE equivalent" branched prosthesis, compared with the cohort of patients already treated with standard prostheses and / or Gelweave ™ Coselli Thoracoabdominal Grafts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of participants who obtain technical success
Time Frame: 12 month
|
number of surviving participants
|
12 month
|
incidence of thrombosis of the prosthetic branches, visceral arteries and replanted intercostal arteries
Time Frame: 12 month
|
freedom from thrombosis of the prosthetic branches,visceral arteries and replanted intercostal arteries
|
12 month
|
incidence of aneurysmal dilatation of visceral and replanted intercostal arteries
Time Frame: 12 month
|
freedom from surgical / endovascular reoperation for aneurysmal dilatation of visceral and replanted intercostal arteries
|
12 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2020
Primary Completion (Actual)
March 1, 2022
Study Completion (Actual)
March 1, 2022
Study Registration Dates
First Submitted
June 9, 2020
First Submitted That Met QC Criteria
June 11, 2020
First Posted (Actual)
June 12, 2020
Study Record Updates
Last Update Posted (Actual)
November 14, 2022
Last Update Submitted That Met QC Criteria
November 10, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLEOPATRA study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm Thoracic
-
Wuhan Asia Heart HospitalFu Wai Hospital, Beijing, ChinaCompletedDissection of Aorta, Thoracic | Aneurysm of Aorta, ThoracicChina
-
Medtronic CardiovascularMedtronicTerminatedThoracic Aortic AneurysmsUnited States
-
Medtronic CardiovascularCompletedThoracic Aortic AneurysmUnited States
-
Cook Research IncorporatedCompletedDescending Thoracic Aortic AneurysmUnited States, Canada
-
Duke Vascular, Inc.Unknown
-
Endovascular FoundationW.L.Gore & Associates; Bocconi UniversityRecruitingThoracic Aorta | Thoracic Aorta Aneurysm | Thoracic Aorta AbnormalitySpain, Italy
-
Gangnam Severance HospitalCompletedDissecting Aneurysm of the Thoracic Aorta | Chronic Dissecting Aneurysm of Thoracic Aorta | Chronic Nontraumatic Dissection of Thoracic AortaKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisCompletedThoracic Aortic AneurysmFrance
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingAneurysm Thoracic | Dissection of Thoracic AortaArgentina, Italy, Germany, Greece, Russian Federation
-
Medtronic CardiovascularCompletedThoracic Aortic AneurysmsUnited States
Clinical Trials on branched prosthesis for surgical treatment of thoraco-abdominal aortic aneurysms
-
University Clinical Centre of KosovaUniversity of Ljubljana, Faculty of MedicineUnknownType 2 Diabetes Mellitus | PeriodontitisKosovo